This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
This quick guide highlights index funds with the lowest turnover, explaining how turnover impacts risk, taxes, and long-term gains.
26,958 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
The U.S. Treasury must refinance about $8 trillion in debt over the next year, a record load that market watchers say...
As gold holds its bid in a backdrop of steady inflation, the iShares Gold Trust SPDR comparison centers on a 0.15% an...
On June 17, US spot Bitcoin ETFs flipped to net red, with total outflows of $82.2 million. The day highlighted a clea...
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
With inflation cooling but living costs persistent, savvy savers are turning to high-yield savings accounts to protec...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Summer markets often hinge on headlines. This guide explains how geopolitical tensions could impact portfolios and of...
A veteran market strategist argues the semiconductor rally is supported by real demand and capacity constraints, not ...
Nebius Group has rocketed more than 240% this year. Before you jump in, learn how to weigh momentum against fundament...